Overview
$1.6M Revenue, fiscal 20212 -$7.8M Net income, fiscal 20212 Industry Biological Products, (No Diagnostic Substances) Headquarters NV Incorporated in NV3 Business address 520 S. Grand Avenue, Suite 320, Los Angeles, Ca 900713 Filer category , Emerging growth company3 See how the biggest companies compare on our leaderboards
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021 5828.9% Revenue growth, 20212 Where the money goes Where each dollar of revenue went, fiscal 2021 Cost of revenue Other costs
Cost of revenue 88¢ $1.4M Other costs 12¢ $184.3K Out of $1.6M in revenue.2
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue4 5 2 $1.6M in 20210 $500.0K $1.0M $1.5M $2.0M 2018: $0 $0 2018 2019: $0 $0 2019 2020: $27.0K $27.0K 2020 2021: $1.6M $1.6M 2021 +5829% Gross profit5 2 $184.3K in 20210 $50.0K $100.0K $150.0K $200.0K 2019: $0 $0 2019 2020: $2.5K $2.5K 2020 2021: $184.3K $184.3K 2021 +7321% Operating income6 7 8 4 5 2 -$1.9M in 2021+4400% since 2015 -$4.0M -$3.0M -$2.0M -$1.0M 0 2015: -$43.2K -$43.2K 2015 2016: -$1.6K -$1.6K 2016 −96% 2017: -$1.4K -$1.4K 2017 −8% 2018: -$51.0K -$51.0K 2018 +3466% 2019: -$549.9K -$549.9K 2019 +978% 2020: -$3.6M -$3.6M 2020 +559% 2021: -$1.9M -$1.9M 2021 −46% Net income6 7 8 4 9 2 -$7.8M in 2021+16191% since 2015 -$8.0M -$6.0M -$4.0M -$2.0M 0 2015: -$48.1K -$48.1K 2015 2016: -$7.8K -$7.8K 2016 −84% 2017: -$8.4K -$8.4K 2017 +8% 2018: -$86.8K -$86.8K 2018 +930% 2019: -$385.4K -$385.4K 2019 +344% 2020: -$4.9M -$4.9M 2020 +1179% 2021: -$7.8M -$7.8M 2021 +59% No quarterly figures reported.
Fiscal year 2014 2015 2016 2017 2018 2019 2020 2021 Revenue $04 $05 $27.0K2 $1.6M2 Cost of revenue $05 $24.5K2 $1.4M2 Gross profit $05 $2.5K2 $184.3K2 Research and development $04 $12.4K4 Operating income -$43.2K6 -$1.6K7 -$1.4K8 -$51.0K4 -$549.9K5 -$3.6M2 -$1.9M2 Income tax $04 $05 $02 $02 Net income -$48.1K6 -$7.8K7 -$8.4K8 -$86.8K4 -$385.4K9 -$4.9M2 -$7.8M2
Total assets6 7 8 4 5 2 $11.3M in 2021+193726% since 2015 0 $5.0M $10.0M $15.0M 2015: $5.8K $5.8K 2015 2016: $5.0K $5.0K 2016 −14% 2017: $4.8K $4.8K 2017 −4% 2018: $4.7K $4.7K 2018 −4% 2019: $214.8K $214.8K 2019 +4518% 2020: $2.3M $2.3M 2020 +982% 2021: $11.3M $11.3M 2021 +388% Total liabilities6 7 8 4 5 2 $10.0M in 2021+12592% since 2015 0 $2.5M $5.0M $7.5M $10.0M 2015: $78.7K $78.7K 2015 2016: $85.6K $85.6K 2016 +9% 2017: $93.9K $93.9K 2017 +10% 2018: $139.6K $139.6K 2018 +49% 2019: $153.4K $153.4K 2019 +10% 2020: $3.8M $3.8M 2020 +2351% 2021: $10.0M $10.0M 2021 +165% Shareholders’ equity7 8 4 5 2 -$2.2M in 2021+2939% since 2015 -$3.0M -$2.0M -$1.0M 0 $1.0M 2015: -$72.8K -$72.8K 2015 2016: -$80.6K -$80.6K 2016 +11% 2017: -$89.1K -$89.1K 2017 +10% 2018: -$135.0K -$135.0K 2018 +52% 2019: $61.4K $61.4K 2019 2020: -$1.4M -$1.4M 2020 2021: -$2.2M -$2.2M 2021 +54% Cash7 8 4 5 2 $30.8K in 2021+427% since 2015 0 $50.0K $100.0K $150.0K $200.0K 2015: $5.8K $5.8K 2015 2016: $5.0K $5.0K 2016 −14% 2017: $4.8K $4.8K 2017 −4% 2018: $4.7K $4.7K 2018 −4% 2019: $152.1K $152.1K 2019 +3169% 2020: $2.3K $2.3K 2020 −98% 2021: $30.8K $30.8K 2021 +1218% No quarterly figures reported.
Fiscal year 2014 2015 2016 2017 2018 2019 2020 2021 Cash $5.8K7 $5.0K8 $4.8K4 $4.7K5 $152.1K2 $2.3K2 $30.8K2 Current assets $5.8K6 $5.0K7 $4.8K8 $4.7K4 $154.4K5 $77.7K2 $442.1K2 Total assets $5.8K6 $5.0K7 $4.8K8 $4.7K4 $214.8K5 $2.3M2 $11.3M2 Current liabilities $78.7K6 $85.6K7 $93.9K8 $139.6K4 $153.4K5 $3.8M2 $8.7M2 Total liabilities $78.7K6 $85.6K7 $93.9K8 $139.6K4 $153.4K5 $3.8M2 $10.0M2 Shareholders’ equity -$72.8K7 -$80.6K8 -$89.1K4 -$135.0K5 $61.4K5 -$1.4M2 -$2.2M2 Shares outstanding 53.9M shares10 53.9M shares6 53.9M shares7 53.9M shares8 183.9M shares8 14.1M shares4 34.8M shares5 134.1M shares2
Cash from operations6 7 8 4 5 2 -$1.5M in 2021+3105% since 2015 -$2.0M -$1.5M -$1.0M -$500.0K 0 2015: -$45.9K -$45.9K 2015 2016: -$838 -$838 2016 −98% 2017: -$180 -$180 2017 −79% 2018: -$35.7K -$35.7K 2018 +19752% 2019: -$109.4K -$109.4K 2019 +206% 2020: -$1.5M -$1.5M 2020 +1291% 2021: -$1.5M -$1.5M 2021 −3% Capital spending4 $14.0K in 20190 $5.0K $10.0K $15.0K 2018: $0 $0 2018 2019: $14.0K $14.0K 2019 Free cash flow4 5 -$123.4K in 2019+245% since 2018 -$150.0K -$100.0K -$50.0K 0 2018: -$35.7K -$35.7K 2018 2019: -$123.4K -$123.4K 2019 +245% Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2014 2015 2016 2017 2018 2019 2020 2021 Cash from operations -$45.9K6 -$8387 -$1808 -$35.7K4 -$109.4K5 -$1.5M2 -$1.5M2 Capital spending $04 $14.0K4 Free cash flow -$35.7K -$123.4K
Compare CANNABIS GLOBAL, INC. with another company
Former names
MCTC Holdings, Inc. Apr 2, 2019 to Apr 6, 20203 MICROCHANNEL TECHNOLOGIES CORP Oct 1, 2007 to Jan 11, 20193
Recent filings
Nov 7, 2022 8-K Oct 5, 2022 8-K/A Sep 12, 2022 8-K Jul 26, 2022 8-K Jul 20, 2022 10-Q May 31, 2022 8-K May 4, 2022 8-K Apr 19, 2022 10-Q Mar 16, 2022 8-K Feb 7, 2022 8-K Jan 18, 2022 10-Q Jan 12, 2022 8-K Dec 14, 2021 10-K Nov 12, 2021 8-K Nov 4, 2021 S-1/A Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
